Dynamic Contrast-Enhanced Magnetic Resonance Imaging Applications

Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) leverages T1-weighted imaging to quantify tissue vascularity and interstitial transport by acquiring serial images before, during and after intravenous injection of a paramagnetic contrast agent. Signal enhancement curves are fitted to tracer kinetic models such as the Tofts or extended Tofts frameworks to yield pharmacokinetic parameters including endothelial transfer constant (Ktrans), plasma volume fraction (vp) and extravascular extracellular space volume fraction (ve). These biomarkers provide noninvasive insight into microvascular perfusion, capillary permeability and tissue composition across a wide range of clinical and preclinical contexts. In oncology, DCE-MRI serves to characterise tumour angiogenesis, guide biopsy, stratify patients for antiangiogenic or chemoradiotherapy regimens and monitor therapeutic response. Cardiovascular applications encompass assessment of myocardial perfusion and capillary integrity, while neurological uses include evaluation of blood–brain barrier disruption in stroke, multiple sclerosis and metastatic disease. Recent advances in acquisition techniques—such as dual-temporal resolution imaging and accelerated k-space undersampling—and in data analysis methods—from nested compartment modelling to machine-learning-based parameter estimation—have expanded the spatial and temporal precision of DCE-MRI. Despite challenges in standardising arterial input function determination and ensuring inter-algorithm reproducibility, ongoing efforts in model validation, multicentre harmonisation and integration with complementary modalities underline the modality’s global significance as a versatile tool for functional tissue characterisation and personalised medicine.

Research from Nature Portfolio

In studies of locally advanced non-small cell lung cancer undergoing concurrent chemo­radiotherapy, quantitative analysis of perfusion and permeability parameters derived from DCE-MRI has been shown to predict early tumour regression. Lower extravascular extracellular space volume fraction and higher transfer constant values in baseline scans correlate with responder status, demonstrating the technique’s potential to guide individualised treatment. Complementary multi-centre investigations into pharmacokinetic parameter calculations have highlighted significant inter-algorithm variability in derived metrics such as Ktrans and ve. Through analysis of digital reference objects and clinical head and neck carcinoma datasets, these studies reveal that noise and algorithmic implementation can affect parameter order and magnitude, underscoring the need for standardised quality-assurance protocols to ensure reliable cross-site comparisons and clinical translation.

Dynamic Contrast-Enhanced Magnetic Resonance Imaging Applications publication trend

The graph below shows the total number of articles in dynamic contrast-enhanced magnetic resonance imaging applications across all publications each year (not limited to Nature Index journals).

Technical terms

Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI): An imaging technique that acquires serial T1-weighted images before, during and after administration of a paramagnetic contrast agent to assess tissue perfusion and permeability.

Tracer kinetic model: A mathematical framework, such as the Tofts or extended Tofts model, used to interpret contrast-agent concentration–time curves and derive physiological parameters.

Endothelial transfer constant (Ktrans): A pharmacokinetic parameter that quantifies the rate at which contrast agent moves from plasma into the extravascular extracellular space.

Extravascular extracellular space volume fraction (ve): The proportion of tissue volume occupied by the extravascular extracellular compartment, reflecting interstitial space.

Arterial input function (AIF): The concentration–time profile of contrast agent in arterial blood, required for accurate pharmacokinetic modelling of DCE-MRI data.

Compartment model: A representation of tissue physiology in which distinct spaces (eg plasma, interstitium) exchange contrast agent according to defined rate constants.

References

1. A proof-of-concept pipeline to guide evaluation of tumor tissue perfusion by dynamic contrast-agent imaging: Direct simulation and inverse tracer-kinetic procedures. Frontiers in Bioinformatics (2023).
2. Structural and practical identifiability of contrast transport models for DCE-MRI. PLOS Computational Biology (2024).
3. Model discovery approach enables noninvasive measurement of intra-tumoral fluid transport in dynamic MRI. APL Bioengineering (2024).
4. The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge. Tomography (2016).
5. Convolutional Neural Networks for Direct Inference of Pharmacokinetic Parameters: Application to Stroke Dynamic Contrast-Enhanced MRI. Frontiers in Neurology (2019).
6. DCE-MRI Perfusion and Permeability Parameters as predictors of tumor response to CCRT in Patients with locally advanced NSCLC. Scientific Reports (2016).
7. A Multi-Institutional Comparison of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameter Calculations. Scientific Reports (2017).
8. Direct parametric reconstruction from undersampled (k, t)-space data in dynamic contrast enhanced MRI. Medical Image Analysis (2014).